Product Data Sheet

MK-5757

Catalog No. A62433

main product photo
MK-5757 is a potent Nociceptin/Orphanin FQ Peptide Receptor antagonist. It has been shown to improve cerebral blood flow and mitigate ischemic damage, making it valuable for studying neurological disorders. This compound is particularly relevant for research into traumatic brain injury and other neurodegenerative conditions characterized by abnormal neurological symptoms.
Chemical Information
Catalog NumA62433
M. Wt425.56
FormulaC25H35N3O3
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.919482-44-3
Synonyms
SMILES[H][C@]1(CC2)C[C@]2([H])C3(CC3)[C@H]1CN4CCC(N5C6=CC=CC=C6N(C5=O)C[C@@H](O)CO)CC4
Biological Activity
DescriptionMK-5757 is a potent Nociceptin/Orphanin FQ Peptide Receptor antagonist. It has been shown to improve cerebral blood flow and mitigate ischemic damage, making it valuable for studying neurological disorders. This compound is particularly relevant for research into traumatic brain injury and other neurodegenerative conditions characterized by abnormal neurological symptoms.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.